MDWD PE Ratio & Valuation,Is MDWD Overvalued

MDWD Relative Valuation

MDWD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MDWD is overvalued; if below, it's undervalued.

Historical Valuation

Mediwound Ltd (MDWD) is now in the Overvalued zone, suggesting that its current forward PS ratio of 8.33 is considered Overvalued compared with the five-year average of -8.05. The fair price of Mediwound Ltd (MDWD) is between 8.06 to 15.31 according to relative valuation methord. Compared to the current price of 19.30 USD , Mediwound Ltd is Overvalued By 26.07%.

Relative Value

Fair Zone

8.06-15.31

Current Price：19.30

26.07%

Overvalued

-7.84

-6.96

EV/EBITDA

Mediwound Ltd. (MDWD) has a current EV/EBITDA of -6.96. The 5-year average EV/EBITDA is -5.22. The thresholds are as follows: Strongly Undervalued below -18.49, Undervalued between -18.49 and -11.86, Fairly Valued between 1.42 and -11.86, Overvalued between 1.42 and 8.05, and Strongly Overvalued above 8.05. The current Forward EV/EBITDA of -6.96 falls within the Historic Trend Line -Fairly Valued range.

-6.45

EV/EBIT

Mediwound Ltd. (MDWD) has a current EV/EBIT of -6.45. The 5-year average EV/EBIT is -5.70. The thresholds are as follows: Strongly Undervalued below -10.48, Undervalued between -10.48 and -8.09, Fairly Valued between -3.31 and -8.09, Overvalued between -3.31 and -0.92, and Strongly Overvalued above -0.92. The current Forward EV/EBIT of -6.45 falls within the Historic Trend Line -Fairly Valued range.

8.33

Mediwound Ltd. (MDWD) has a current PS of 8.33. The 5-year average PS is 5.36. The thresholds are as follows: Strongly Undervalued below 1.45, Undervalued between 1.45 and 3.41, Fairly Valued between 7.32 and 3.41, Overvalued between 7.32 and 9.28, and Strongly Overvalued above 9.28. The current Forward PS of 8.33 falls within the Overvalued range.

-5.75

P/OCF

Mediwound Ltd. (MDWD) has a current P/OCF of -5.75. The 5-year average P/OCF is -8.03. The thresholds are as follows: Strongly Undervalued below -27.36, Undervalued between -27.36 and -17.69, Fairly Valued between 1.64 and -17.69, Overvalued between 1.64 and 11.30, and Strongly Overvalued above 11.30. The current Forward P/OCF of -5.75 falls within the Historic Trend Line -Fairly Valued range.

-5.40

P/FCF

Mediwound Ltd. (MDWD) has a current P/FCF of -5.40. The 5-year average P/FCF is -3.53. The thresholds are as follows: Strongly Undervalued below -12.41, Undervalued between -12.41 and -7.97, Fairly Valued between 0.90 and -7.97, Overvalued between 0.90 and 5.34, and Strongly Overvalued above 5.34. The current Forward P/FCF of -5.40 falls within the Historic Trend Line -Fairly Valued range.

Mediwound Ltd (MDWD) has a current Price-to-Book (P/B) ratio of 4.71. Compared to its 3-year average P/B ratio of 5.87 , the current P/B ratio is approximately -19.78% higher. Relative to its 5-year average P/B ratio of 4.48, the current P/B ratio is about 5.04% higher. Mediwound Ltd (MDWD) has a Forward Free Cash Flow (FCF) yield of approximately -7.88%. Compared to its 3-year average FCF yield of -11.37%, the current FCF yield is approximately -30.71% lower. Relative to its 5-year average FCF yield of -12.80% , the current FCF yield is about -38.49% lower.

4.71

P/B

Median3y

5.87

Median5y

4.48

-7.88

FCF Yield

Median3y

-11.37

Median5y

-12.80

Competitors Valuation Multiple

The average P/S ratio for MDWD's competitors is 3.29, providing a benchmark for relative valuation. Mediwound Ltd Corp (MDWD) exhibits a P/S ratio of 8.33, which is 153.37% above the industry average. Given its robust revenue growth of 24.66%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of MDWD decreased by 1.07% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -6.32 to -9.71.

The secondary factor is the Revenue Growth, contributed 24.66%to the performance.

Overall, the performance of MDWD in the past 1 year is driven by P/E Change. Which is more unsustainable.

24.66%

4.36M → 5.43M

Revenue Growth

-79.31%

-236.10 → -48.85

Margin Expansion

53.58%

-6.32 → -9.71

P/E Change

-1.07%

19.58 → 19.37

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Mediwound Ltd (MDWD) currently overvalued or undervalued?

What is Mediwound Ltd (MDWD) fair value?

MDWD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Mediwound Ltd (MDWD) is between 8.06 to 15.31 according to relative valuation methord.

How does MDWD's valuation metrics compare to the industry average?

What is the current P/B ratio for Mediwound Ltd (MDWD) as of Jan 09 2026?

As of Jan 09 2026, Mediwound Ltd (MDWD) has a P/B ratio of 4.71. This indicates that the market values MDWD at 4.71 times its book value.

What is the current FCF Yield for Mediwound Ltd (MDWD) as of Jan 09 2026?

As of Jan 09 2026, Mediwound Ltd (MDWD) has a FCF Yield of -7.88%. This means that for every dollar of Mediwound Ltd’s market capitalization, the company generates -7.88 cents in free cash flow.

What is the current Forward P/E ratio for Mediwound Ltd (MDWD) as of Jan 09 2026?

As of Jan 09 2026, Mediwound Ltd (MDWD) has a Forward P/E ratio of -7.84. This means the market is willing to pay $-7.84 for every dollar of Mediwound Ltd’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Mediwound Ltd (MDWD) as of Jan 09 2026?

As of Jan 09 2026, Mediwound Ltd (MDWD) has a Forward P/S ratio of 8.33. This means the market is valuing MDWD at $8.33 for every dollar of expected revenue over the next 12 months.

MDWD Valuation